Michelle Lock was appointed Chief Executive Officer ad interim of Relief Therapeutics on June 3, 2024.
Michelle Lock was appointed Chief Executive Officer ad interim of Relief Therapeutics on June 3, 2024. She was previously the Chief Operating Officer of the company, a position she held since April 2023. She has extensive experience in the pharmaceutical and biotechnology industries.
Full founder directory · Investor directory · Company funding database · Fundraising library